Corporate DisclosureSQURPHARMA
SQURPHARMA Corporate Disclosure — 18 February 2020
Announcement summary
- What happened
- SQURPHARMA published a corporate disclosure on 18 February 2020. Read the full announcement for details.
- Company
- Square Pharmaceuticals PLC.
- Announcement published
Original announcement
(Continuation news of SQURPHARMA): ii) Initial estimated total cost will be Tk. 350.00 crore and to be financed by internally generated funds by the Square Pharmaceuticals Ltd. /Sponsors of Square Lifesciences Ltd. and iii) It is expected that the project would be completed by June, 2023. (end)
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 616aceb25a6b000040057691
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from SQURPHARMA
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.